* Immunocellular Therapeutics reports updated immune monitoring data from ICT-107 phase 2 trial in newly diagnosed glioblastoma at the society for neuro-oncology annual meeting 2016 Sign up here. * ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback